Iñaki Etxeberría (Inaki Etxeberria, Iñaki Etxeberria)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Systemic Lupus Erythematosus

Top Venues

bioRxiv : the preprint server for biology

Cancer discovery

Cancer immunology research

Cellular & molecular immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Fei Yi, Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib, Erica J Brophy, Hannah Arkin, Judith Feucht, Michael V Gormally, Christopher S Hackett, Korbinian N Kropp, Iñaki Etxeberría, Smita S Chandran, Jae H Park, Katharine C Hsu, Michel Sadelain, Doron Betel, Christopher A Klebanoff
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit. bioRxiv : the preprint server for biology (2024)
Fei Yi, Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib, Erica J Brophy, Hannah Arkin, Judith Feucht, Michael V Gormally, Christopher S Hackett, Korbinian N Kropp, Iñaki Etxeberría, Smita S Chandran, Jae H Park, Katharine C Hsu, Michel Sadelain, Doron Betel, Christopher A Klebanoff
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit. bioRxiv : the preprint server for biology (2024)
Fei Yi, Tal Cohen, Natalie Zimmerman, Friederike Dündar, Paul Zumbo, Razan Eltilib, Erica J Brophy, Hannah Arkin, Judith Feucht, Michael V Gormally, Christopher S Hackett, Korbinian N Kropp, Iñaki Etxeberría, Smita S Chandran, Jae H Park, Katharine C Hsu, Michel Sadelain, Doron Betel, Christopher A Klebanoff
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit. bioRxiv : the preprint server for biology (2024)
Irene Olivera, Vicente Martín, Elixabet Bolaños, Inmaculada Rodriguez, Iñaki Etxeberría, Assunta Cirella, Josune Egea, Saray Garasa, Itziar Migueliz, Iñaki Eguren, Miguel F Sanmamed, Javier Glez-Vaz, Arantza Azpilikueta, Maite Alvarez, María Carmen Ochoa, Beatrice Malacrida, David J Propper, Carlos E De Andrea, Pedro Berraondo, Frances R Balkwill, Alvaro Teijeira, Ignacio Melero Bermejo
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β. Cancer discovery 12 (9) (2022)
Smita S Chandran, Jiaqi Ma, Martin G Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y Wen, Jorge S Reis-Filho, Paul Zumbo, Si Ning Fu, Lauren B Banks, Fei Yi, Enric Vercher, Iñaki Etxeberría, Watchain D Bestman, Arnaud Da Cruz Paula, Ilinca S Aricescu, Alexander E Drilon, Doron Betel, David A Scheinberg, Brian M Baker, Christopher A Klebanoff
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA. Nature medicine 28 (5) (2022)
Assunta Cirella, Elixabet Bolaños, Claudia Augusta Di Trani, Carlos E De Andrea, Sandra Sanchez-Gregorio, Iñaki Etxeberría, Jose Gonzalez-Gomariz, Irene Olivera, Davide Brocco, Javier Glez-Vaz, Carlos Luri-Rey, Arantza Azpilikueta, Inmaculada Rodriguez, Myriam Fernandez-Sendin, Josune Egea, Iñaki Eguren, Miguel F Sanmamed, Belen Palencia, Alvaro Teijeira, Pedro Berraondo, Ignacio Melero Bermejo
Intratumoral gene transfer of mRNAs encoding interleukin-12 in combination with decoy-resistant interleukin-18 improves local and systemic antitumor immunity. Cancer immunology research (2022)
Iñaki Etxeberría, Elixabet Bolaños, Alvaro Teijeira, Saray Garasa, Alba Yanguas, Arantza Azpilikueta, William M Kavanaugh, Olga Vasiljeva, Marcia Belvin, Bruce Howng, Bryan Irving, Kimberly Tipton, James West, Li Mei, Alan J Korman, Emanuela Sega, Irene Olivera, Assunta Cirella, María Carmen Ochoa, Maria E Rodríguez-Ruiz, Ana Melero, Miguel F Sanmamed, John J Engelhardt, Ignacio Melero Bermejo
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic. Proceedings of the National Academy of Sciences of the United States of America 118 (26) (2021)
Itziar Otano, Arantza Azpilikueta, Javier Glez-Vaz, Maite Alvarez, José Medina-Echeverz, Ivan Cortés-Domínguez, Carlos Ortiz de Solórzano, Peter Ellmark, Sara Fritzell, Gabriela Hernandez-Hoyos, Michelle Hase Nelson, María Carmen Ochoa, Elixabet Bolaños, Doina Cuculescu, Patricia Jaúregui, Sandra Sanchez-Gregorio, Iñaki Etxeberría, María E Rodriguez-Ruiz, Miguel F Sanmamed, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero Bermejo
CD137 (4-1BB) costimulation of CD8 + T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation. Nature communications 12 (1) (2021)
Irene Olivera, Iñaki Etxeberría, Elixabet Bolaños, María Gato-Cañas, Ignacio Melero
Exploiting TCR Recognition of Shared Hotspot Oncogene-encoded Neoantigens. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2020)
Miguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, Ignacio Melero
Twists and turns to translating 4-1BB cancer immunotherapy. Science translational medicine 11 (496) (2020)
Alvaro Teijeira, Saray Garasa, Iñaki Etxeberría, Maria Gato-Cañas, Ignacio Melero, Greg M Delgoffe
Metabolic Consequences of T-cell Costimulation in Anticancer Immunity. Cancer immunology research 7 (10) (2020)
Iñaki Etxeberría, Irene Olivera, Elixabet Bolaños, Asunta Cirella, Álvaro Teijeira, Pedro Berraondo, Ignacio Melero
Engineering bionic T cells: signal 1, signal 2, signal 3, reprogramming and the removal of inhibitory mechanisms. Cellular & molecular immunology 17 (6) (2020)
María E Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, Tania Labiano, Benigno Barbes, Iñaki Etxeberría, Mariano Ponz-Sarvisé, Arantza Azpilikueta, Elixabet Bolaños, Miguel F Sanmamed, Pedro Berraondo, Felipe A Calvo, Mary Helen Barcelos-Hoff, Jose L Perez-Gracia, Ignacio Melero
TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies. Molecular cancer therapeutics 18 (3) (2019)
Iñaki Etxeberría, Alvaro Teijeira, Luis M Montuenga, Pedro Berraondo, Ignacio Melero
Epistatic Oncogenic Interactions Determine Cancer Susceptibility to Immunotherapy. Cancer discovery 8 (7) (2019)
Alfonso R Sánchez-Paulete, Alvaro Teijeira, José I Quetglas, María E Rodríguez-Ruiz, Álvaro Sánchez-Arráez, Sara Labiano, Iñaki Etxeberría, Arantza Azpilikueta, Elixabet Bolaños, María Cristina Ballesteros-Briones, Noelia Casares, Sergio A Quezada, Pedro Berraondo, David Sancho, Cristian Smerdou, Ignacio Melero
Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T-cell Cross-Priming. Cancer research 78 (23) (2018)